Clinical Journal of the American Society of Nephrology

Papers
(The H4-Index of Clinical Journal of the American Society of Nephrology is 46. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Humoral Response to the Pfizer BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis251
Kidney Disease, Race, and GFR Estimation159
Acute Kidney Injury in a National Cohort of Hospitalized US Veterans with COVID-19147
Clinical Features of Maintenance Hemodialysis Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China128
Mitigating Risk of COVID-19 in Dialysis Facilities127
Esaxerenone (CS-3150) in Patients with Type 2 Diabetes and Microalbuminuria (ESAX-DN)115
APOL1 Nephropathy: From Genetics to Clinical Applications111
Systematic Review and Meta-Analysis of Native Kidney Biopsy Complications98
Impending Shortages of Kidney Replacement Therapy for COVID-19 Patients94
A Primer on Congenital Anomalies of the Kidneys and Urinary Tracts (CAKUT)89
Early Humoral Responses of Hemodialysis Patients after COVID-19 Vaccination with BNT162b288
Effects of Canagliflozin in Patients with Baseline eGFR <30 ml/min per 1.73 m286
Social Determinants of Health and Race Disparities in Kidney Transplant82
Efficacy and Safety of Daprodustat Compared with Darbepoetin Alfa in Japanese Hemodialysis Patients with Anemia77
The Incidence, Risk Factors, and Prognosis of Acute Kidney Injury in Adult Patients with Coronavirus Disease 201977
Early Outcomes of Outpatient Management of Kidney Transplant Recipients with Coronavirus Disease 201975
Klotho in Clinical Nephrology71
Classification of Uremic Toxins and Their Role in Kidney Failure71
Drug-Induced Acute Kidney Injury71
Sound Science before Quick Judgement Regarding RAS Blockade in COVID-1969
Insights into Autosomal Dominant Polycystic Kidney Disease from Genetic Studies68
COVID-19 and the Inpatient Dialysis Unit68
Skeletal Muscle Mitochondrial Dysfunction Is Present in Patients with CKD before Initiation of Maintenance Hemodialysis66
Precision in GFR Reporting64
Clinical Implications of an Acute Dip in eGFR after SGLT2 Inhibitor Initiation63
Identifying Outcomes Important to Patients with Glomerular Disease and Their Caregivers63
Lessons from the Experience in Wuhan to Reduce Risk of COVID-19 Infection in Patients Undergoing Long-Term Hemodialysis62
Apixaban versus No Anticoagulation in Patients Undergoing Long-Term Dialysis with Incident Atrial Fibrillation62
Risk Factors for CKD Progression61
Pathophysiology and Treatment of Enteric Hyperoxaluria58
AKI!Now Initiative: Recommendations for Awareness, Recognition, and Management of AKI57
Utilization of Deep Learning for Subphenotype Identification in Sepsis-Associated Acute Kidney Injury57
Cuffless Blood Pressure Monitoring53
Fatigue in CKD52
Network Meta-Analysis of Novel Glucose-Lowering Drugs on Risk of Acute Kidney Injury52
Clinical Genetic Screening in Adult Patients with Kidney Disease51
End Points for Clinical Trials in Primary Hyperoxaluria51
Evidence For and Against Direct Kidney Infection by SARS-CoV-2 in Patients with COVID-1951
Guidelines for Genetic Testing and Management of Alport Syndrome47
Inherited Tubulopathies of the Kidney47
Major Bleeding and Risk of Death after Percutaneous Native Kidney Biopsies47
Developments in the Histopathological Classification of ANCA-Associated Glomerulonephritis47
Adverse Drug Reactions in Patients with CKD47
COVID-19–Associated Mortality among Kidney Transplant Recipients and Candidates in the United States47
Long-Term Outcomes in IgA Nephropathy46
Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 146
0.026081085205078